Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A

An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis - BAMC